N-butyl-N-ethyl-3-{2-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]ethyl}[1,2,4]triazolo[4,3-b]pyridazin-6-amine结构式
|
常用名 | N-butyl-N-ethyl-3-{2-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]ethyl}[1,2,4]triazolo[4,3-b]pyridazin-6-amine | 英文名 | N-butyl-N-ethyl-3-{2-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]ethyl}[1,2,4]triazolo[4,3-b]pyridazin-6-amine |
|---|---|---|---|---|
| CAS号 | 1113110-33-0 | 分子量 | 420.5 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C19H24N4O5S | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
| 英文名 | N-butyl-N-ethyl-3-{2-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]ethyl}[1,2,4]triazolo[4,3-b]pyridazin-6-amine |
|---|
| 分子式 | C19H24N4O5S |
|---|---|
| 分子量 | 420.5 |
| InChIKey | IVYNXZXRWASXMI-UHFFFAOYSA-N |
| SMILES | Cn1c(=O)n(CCC(=O)N2CCCC2)c(=O)c2cc(S(=O)(=O)NC3CC3)ccc21 |
|
实验名称:High-throughput screen for inhibitors of the GIV GBA-motif interaction with Galpha-i ...
来源:ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
External Id:HMS1303
|